We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Concentrix
CNXC
$1.78B
| $515K | ﹤0.01% |
6,377
+272
| +4% | +$25.4K |
|
1352
Antero Midstream
AM
$10B
| $514K | ﹤0.01% |
44,297
+10,806
| +32% | +$115K |
|
1353
Digital Realty Trust
DLR
$67.2B
| $513K | ﹤0.01% |
4,506
-502,469
| -99% | -$49.7M |
|
1354
Amkor Technology
AMKR
$11.5B
| $513K | ﹤0.01% |
17,234
+472
| +3% | +$11.5K |
|
1355
DT Midstream
DTM
$12.8B
| $513K | ﹤0.01% |
10,342
-1,435
| -12% | -$68.7K |
|
1356
MACOM Technology Solutions
MTSI
$19.2B
| $510K | ﹤0.01% |
7,786
+2,443
| +46% | +$148K |
|
1357
Globus Medical
GMED
$10.1B
| $508K | ﹤0.01% |
8,535
-2,955
| -26% | -$168K |
|
1358
VeriSign
VRSN
$27B
| $505K | ﹤0.01% |
2,236
+792
| +55% | +$175K |
|
1359
10x Genomics
TXG
$9.47B
| $505K | ﹤0.01% |
9,045
-1,586
| -15% | -$85.8K |
|
|
COOP
1360
DELISTED
Mr. Cooper
COOP
| $503K | ﹤0.01% |
+9,934
| New | +$455K |
|
1361
Check Point Software Technologies
CHKP
$14.1B
| $502K | ﹤0.01% |
4,000
| – | – |
|
1362
Schrodinger
SDGR
$1.79B
| $499K | ﹤0.01% |
10,000
-50,956
| -84% | -$1.72M |
|
1363
Frontdoor
FTDR
$5.55B
| $499K | ﹤0.01% |
15,632
-10,280
| -40% | -$306K |
|
1364
Ziff Davis
ZD
$2.01B
| $498K | ﹤0.01% |
7,115
+458
| +7% | +$31.3K |
|
|
NSTG
1365
DELISTED
NanoString Technologies, Inc.
NSTG
| $498K | ﹤0.01% |
122,957
-334,184
| -73% | -$2.47M |
|
|
WWE
1366
DELISTED
World Wrestling Entertainment
WWE
| $496K | ﹤0.01% |
4,570
+73
| +2% | +$7.55K |
|
1367
National Bank Holdings
NBHC
$1.84B
| $496K | ﹤0.01% |
17,069
-4,314
| -20% | -$135K |
|
1368
Rayonier
RYN
$5.96B
| $493K | ﹤0.01% |
17,303
-1,127
| -6% | -$31.4K |
|
1369
Cogent Communications
CCOI
$444M
| $493K | ﹤0.01% |
7,323
+19
| +0.3% | +$1.24K |
|
1370
1st Source
SRCE
$2.07B
| $490K | ﹤0.01% |
11,694
+1
| +0% | +$43 |
|
1371
Resources Connection
RGP
$139M
| $490K | ﹤0.01% |
31,171
-21,326
| -41% | -$332K |
|
1372
Neogen
NEOG
$2.74B
| $487K | ﹤0.01% |
22,399
-758
| -3% | -$13.7K |
|
1373
Glacier Bancorp
GBCI
$5.85B
| $486K | ﹤0.01% |
15,579
-1,154
| -7% | -$38.1K |
|
1374
Clear Secure
YOU
$4.19B
| $484K | ﹤0.01% |
20,892
-3,857
| -16% | -$95.3K |
|
1375
Marriott Vacations Worldwide
VAC
$3.49B
| $484K | ﹤0.01% |
3,941
-1,387
| -26% | -$179K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.